Page 44 - 《中国药房》2026年3期
P. 44
PI3K、HIF-1α的mRNA及其蛋白表达水平均显著降低, Fructus Forsythiae herb chito-oligosaccharide via integral
细胞上清液中IL-10水平显著升高。这提示,连翘-金银花 pharmacokinetics[J]. Molecules,2017,22(4):654.
药对减轻ALI引发的炎症反应的作用可能与上调血清外 [12] 秦丽,向盈,李涵,等. 益气活血方对脂多糖致急性肺损
泌体中miR-345-3p表达,抑制HIF-1信号通路活性有关。 伤大鼠肺气血屏障功能的影响[J]. 北京中医药大学学
报,2024,47(12):1702-1709.
综上所述,连翘-金银花药对可通过上调血清外泌
[13] 黄继汉,黄晓晖,陈志扬,等. 药理试验中动物间和动物
体中 miR-345-3p 表达,抑制 HIF-1 信号通路活性,从而
与人体间的等效剂量换算[J]. 中国临床药理学与治疗
减轻炎症反应,进而发挥改善 ALI 的作用。然而,本研
学,2004,9(9):1069-1072.
究仍存在一定局限性,如未对连翘-金银花药对调控外 [14] 余亚辉,吕田田,薛丙权,等. 外泌体装载连翘酯苷A 递
泌体分泌及体内递送的具体上游机制进行深入探讨,未 药系统的制备及体外评价[J]. 中国中药杂志,2021,46
设置阳性对照药组和单味药对照组进行全面药效评估, (11):2824-2829.
未采用 HIF-1 信号通路抑制剂进行反向验证。后续,本 [15] WEI Q,TU Y Z,ZUO L,et al. miR-345-3p attenuates
课题组将弥补上述不足,深入考察连翘-金银花药对改 apoptosis and inflammation caused by oxidized low-
善ALI的作用机制。 density lipoprotein by targeting TRAF6 via TAK1/p38/
参考文献 NF-κB signaling in endothelial cells[J]. Life Sci,2020,
[ 1 ] LIANG D J,SUN Y,SHEN Y B,et al. Shikonin exerts 241:117142.
[16] DAI Y,YI X L,HUANG Y H,et al. miR-345-3p modu‐
anti-inflammatory effects in a murine model of lipopoly-
saccharide-induced acute lung injury by inhibiting the lates M1/M2 macrophage polarization to inhibit inflamma‐
tion in bone infection via targeting MAP3K1 and NF-κB
nuclear factor-κB signaling pathway[J]. Int Immunophar‐
pathway[J]. J Immunol,2024,212(5):844-854.
macol,2013,16(4):475-480.
[ 2 ] 李康,吕田田,崔荣洽,等. 基于血清代谢组学探讨青翘、 [17] MI H Y,HUANG X S,MURUGANUJAN A,et al.
PANTHER version 11:expanded annotation data from
老翘对急性肺损伤大鼠的作用机制[J]. 中国实验方剂学
杂志,2024,30(18):89-97. gene ontology and reactome pathways,and data analysis
[ 3 ] 张稚鲲,王若尧,陈仁寿. 古今肺系疫病方配伍特点对比 tool enhancements[J]. Nucleic Acids Res,2017,45(D1):
D183-D189.
研究[J]. 中医药信息,2018,35(4):73-76.
[ 4 ] WEN X,CHENG M,SONG Z X,et al. Molecular mecha‐ [18] DU N,LIN H M,ZHANG A Q,et al. N-phenethyl-5-
phenylpicolinamide alleviates inflammation in acute lung
nism of honeysuckle + forsythia in treatment of acute lung
injury by inhibiting HIF-1α/glycolysis/ASIC1a pathway
injury based on network pharmacology[J]. Biomed Rep, [J]. Life Sci,2022,309:120987.
2024,20(2):32.
[19] QIAN F H,HE S C,YANG X M,et al. Circular RNA
[ 5 ] 薛丙权,朱艳慧,余海艳,等. 基于UPLC-Q-TOF-MS/MS DHTKD1 targets miR-338-3p/ETS1 axis to regulate the
和网络药理学研究连翘治疗急性肺损伤的作用机制[J].
inflammatory response in human bronchial epithelial cells
中国医院药学杂志,2022,42(21):2208-2215.
[J]. Exp Ther Med,2023,26(1):316.
[ 6 ] ZHOU Y,LI P F,GOODWIN A J,et al. Exosomes from [20] 谢淑敏,郭淑杰,薛丙权,等 . 基于树突细胞外泌体
endothelial progenitor cells improve the outcome of a mu‐
miRNA 探究人参皂苷 Rg1改善慢性阻塞性肺疾病的作
rine model of sepsis[J]. Mol Ther,2018,26(5):1375- 用机制[J]. 中国医院药学杂志,2025,45(10):1140-1146.
1384.
[21] ZHANG J H,TIAN W Y,WANG F,et al. Advancements
[ 7 ] YI X M,WEI X X,LV H J,et al. Exosomes derived from
in understanding the role of microRNAs in regulating
microRNA-30b-3p-overexpressing mesenchymal stem macrophage polarization during acute lung injury[J]. Cell
cells protect against lipopolysaccharide-induced acute
Cycle,2023,22(14/15/16):1694-1712.
lung injury by inhibiting SAA3[J]. Exp Cell Res,2019, [22] 丁晓彦,林志军,王岱 . 金银花-连翘药对的成分和药理
383(2):111454. 作用研究进展[J]. 山东科学,2019,32(3):36-41.
[ 8 ] ZHANG D,LEE H,WANG X Y,et al. A potential role of [23] HUANG J J,XIA J,HUANG L L,et al. HIF-1α promotes
microvesicle-containing miR-223/142 in lung inflamma‐ NLRP3 inflammasome activation in bleomycin-induced
tion[J]. Thorax,2019,74(9):865-874. acute lung injury[J]. Mol Med Rep,2019,20(4):3424-
[ 9 ] 黄宁,胡长平. 外泌体在肺部疾病中的研究进展[J]. 中国 3432.
药理学通报,2023,39(11):2006-2011. [24] ECKLE T,BRODSKY K,BONNEY M,et al. HIF1A re‐
[10] LV K Y,LIANG Q. Macrophages in sepsis-induced acute duces acute lung injury by optimizing carbohydrate me‐
lung injury:exosomal modulation and therapeutic potential tabolism in the alveolar epithelium[J]. PLoS Biol,2013,11
[J]. Front Immunol,2025,15:1518008. (9):e1001665.
[11] ZHOU W,YIN A L,SHAN J J,et al. Study on the rationa- (收稿日期:2025-08-20 修回日期:2026-01-15)
lity for antiviral activity of Flos Lonicerae Japonicae- (编辑:唐晓莲)
· 310 · China Pharmacy 2026 Vol. 37 No. 3 中国药房 2026年第37卷第3期

